-+ 0.00%
-+ 0.00%
-+ 0.00%

Kedrion: at ESID 2026, experts call for earlier diagnosis and greater awareness as Secondary Immunodeficiencies continue to rise

Barchart·10/14/2026 03:00:00
Listen to the news

MAASTRICHT, Netherlands, Oct. 14, 2026 /PRNewswire/ -- Secondary Immunodeficiencies (SIDs) represent a significant and frequently under-recognized healthcare challenge. Their clinical relevance has increased with the expanding use of immunosuppressive and biologic therapies, advances in the treatment of hematological malignancies, and the growing number of patients exposed to conditions associated with acquired immune dysfunction.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.